LYRA 8-K 2026-01-12

Lyra Therapeutics, Inc. (LYRA) 8-K dated 2026-01-12 — accession 0001193125-26-009772. This URL is the filing, not the LYRA hub.

Lyra Therapeutics, Inc. (LYRA) is a biotechnology company listed on US.

Lyra Therapeutics, Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009772.

Cached items: 2.05, 5.02, 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.

Not investment advice. The LYRA SEC hub lists recent forms. The stock page is the research view.